Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.

@article{Saisho2011PostprandialSC,
  title={Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.},
  author={Yoshifumi Saisho and Kinsei Kou and Kumiko Tanaka and Takayuki Abe and Hideaki Kurosawa and Akira Shimada and Shu Meguro and Toshihide Kawai and Hiroshi Itoh},
  journal={Endocrine journal},
  year={2011},
  volume={58 4},
  pages={315-22}
}
Type 2 diabetes is a progressive disease and most patients with type 2 diabetes eventually need insulin therapy. The objective of this study was to clarify C-peptide immunoreactivity (CPR), a marker of beta cell function, as a predictor of requirement for insulin therapy. We conducted a retrospective study of 579 consecutive subjects with type 2 diabetes who were admitted to our hospital from 2000 to 2007 and were able to be followed up for at least 6 months after discharge. Fasting and… CONTINUE READING